instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Therapy cessation'? | Alectinib-Induced Pleural and Pericardial Effusions in ALK-Positive NSCLC.
Alectinib is the first-line targeted treatment for advanced ALK-positive non-small-cell lung cancer. Although it has a relatively mild toxicity profile, adverse events (AEs) do occur. We present a case of alectinib-induced bilateral pleural effu... | Recovering | ReactionOutcome | CC BY-NC | 34720935 | 20,700,796 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report and Literature Review.
Pulmonary tumor thrombotic microangiopathy is a fatal disease secondary to some malignant tumors, such as gastric cancer, esophageal cancer, and pancreatic cancer. A 61-year-old man presen... | CISPLATIN, FLUOROURACIL | DrugsGivenReaction | CC BY-NC | 34720936 | 20,482,655 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report and Literature Review.
Pulmonary tumor thrombotic microangiopathy is a fatal disease secondary to some malignant tumors, such as gastric cancer, esophageal cancer, and pancreatic cancer. A 61-year-old man presen... | CISPLATIN, FLUOROURACIL | DrugsGivenReaction | CC BY-NC | 34720936 | 20,482,655 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report and Literature Review.
Pulmonary tumor thrombotic microangiopathy is a fatal disease secondary to some malignant tumors, such as gastric cancer, esophageal cancer, and pancreatic cancer. A 61-year-old man presen... | CISPLATIN, FLUOROURACIL | DrugsGivenReaction | CC BY-NC | 34720936 | 20,482,655 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report and Literature Review.
Pulmonary tumor thrombotic microangiopathy is a fatal disease secondary to some malignant tumors, such as gastric cancer, esophageal cancer, and pancreatic cancer. A 61-year-old man presen... | LOW DOSE | DrugDosageText | CC BY-NC | 34720936 | 20,482,655 | 2021 |
What was the dosage of drug 'FLUOROURACIL'? | Pulmonary Tumor Thrombotic Microangiopathy Secondary to Extramammary Paget's Disease: An Autopsy Case Report and Literature Review.
Pulmonary tumor thrombotic microangiopathy is a fatal disease secondary to some malignant tumors, such as gastric cancer, esophageal cancer, and pancreatic cancer. A 61-year-old man presen... | LOW DOSE | DrugDosageText | CC BY-NC | 34720936 | 20,482,655 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | CARBOPLATIN, DEXAMETHASONE, DOCETAXEL, IBUPROFEN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34720944 | 20,034,796 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukocytosis'. | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | CARBOPLATIN, DEXAMETHASONE, DOCETAXEL, FILGRASTIM, IBUPROFEN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34720944 | 20,121,291 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutrophil count increased'. | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | CARBOPLATIN, DEXAMETHASONE, DOCETAXEL, FILGRASTIM, IBUPROFEN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34720944 | 20,121,291 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | CARBOPLATIN, DEXAMETHASONE, DOCETAXEL, FILGRASTIM, IBUPROFEN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34720944 | 20,121,291 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper gastrointestinal haemorrhage'. | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | CARBOPLATIN, DOCETAXEL, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, IBUPROFEN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34720944 | 19,987,217 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count increased'. | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | CARBOPLATIN, DEXAMETHASONE, DOCETAXEL, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, IBUPROFEN, PERTUZUMAB, TRASTUZUMAB | DrugsGivenReaction | CC BY-NC | 34720944 | 19,979,945 | 2021 |
What was the outcome of reaction 'Diarrhoea'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Duodenal ulcer'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Gastritis erosive'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,034,796 | 2021 |
What was the outcome of reaction 'Haemoglobin decreased'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Melaena'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Small intestinal haemorrhage'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 20,008,284 | 2021 |
What was the outcome of reaction 'Upper gastrointestinal haemorrhage'? | Taxane-Induced Upper Gastrointestinal Bleeding.
Docetaxel is a taxane, which is a class of chemotherapy agent used in the treatment of multiple malignancies. It is known to have gastrointestinal side effects which can range from mild symptoms such as nausea and diarrhea to more severe complications such as neutropenic ... | Recovered | ReactionOutcome | CC BY-NC | 34720944 | 19,987,217 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysgeusia'. | A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing Chemoimmunotherapy.
A 65-year-old woman with prolonged cough and presumed pulmonary hypertrophic osteoarthropathy was referred to our hospital. Computed tomography showed 2 tum... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY-NC | 34720945 | 20,006,726 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral nerve palsy'. | A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing Chemoimmunotherapy.
A 65-year-old woman with prolonged cough and presumed pulmonary hypertrophic osteoarthropathy was referred to our hospital. Computed tomography showed 2 tum... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY-NC | 34720945 | 20,006,726 | 2021 |
What is the weight of the patient? | A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing Chemoimmunotherapy.
A 65-year-old woman with prolonged cough and presumed pulmonary hypertrophic osteoarthropathy was referred to our hospital. Computed tomography showed 2 tum... | 48.2 kg. | Weight | CC BY-NC | 34720945 | 20,006,726 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing Chemoimmunotherapy.
A 65-year-old woman with prolonged cough and presumed pulmonary hypertrophic osteoarthropathy was referred to our hospital. Computed tomography showed 2 tum... | (AUC 5 MG/ML/MIN Q3W), | DrugDosageText | CC BY-NC | 34720945 | 20,006,726 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing Chemoimmunotherapy.
A 65-year-old woman with prolonged cough and presumed pulmonary hypertrophic osteoarthropathy was referred to our hospital. Computed tomography showed 2 tum... | (400 MG Q3W), | DrugDosageText | CC BY-NC | 34720945 | 20,006,726 | 2021 |
What was the dosage of drug 'PEMETREXED'? | A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing Chemoimmunotherapy.
A 65-year-old woman with prolonged cough and presumed pulmonary hypertrophic osteoarthropathy was referred to our hospital. Computed tomography showed 2 tum... | 500 MG/M2 Q3W | DrugDosageText | CC BY-NC | 34720945 | 20,006,726 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report.
Many cancer patients use integrative therapies with a combination of natural products and diets. In the Weste... | ABEMACICLIB, LETROZOLE, LOPERAMIDE | DrugsGivenReaction | CC BY-NC | 34720948 | 20,408,038 | 2021 |
What was the outcome of reaction 'Diarrhoea'? | Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report.
Many cancer patients use integrative therapies with a combination of natural products and diets. In the Weste... | Recovering | ReactionOutcome | CC BY-NC | 34720948 | 20,396,554 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report.
Many cancer patients use integrative therapies with a combination of natural products and diets. In the Weste... | Recovering | ReactionOutcome | CC BY-NC | 34720948 | 20,374,129 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab.
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy... | GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34720950 | 20,143,993 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect product administration duration'. | A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab.
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC | 34720950 | 20,083,980 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab.
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy... | FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34720950 | 20,097,761 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab.
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy... | FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34720950 | 20,109,290 | 2021 |
What was the dosage of drug 'LEUCOVORIN'? | A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab.
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy... | UNK (8 CYCLES) | DrugDosageText | CC BY-NC | 34720950 | 20,083,706 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab.
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy... | EVERY 3 WEEKS, 44 CYCLES | DrugDosageText | CC BY-NC | 34720950 | 20,083,980 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | CARBOPLATIN, CISPLATIN, LORAZEPAM, PEMETREXED, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,084,822 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CARBOPLATIN, CISPLATIN, DEXAMETHASONE, FERROUS FUMARATE, FOLIC ACID, HERBALS, HYDROMORPHONE, LORAZEPAM, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VITAMINS, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,099,668 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CARBOPLATIN, CISPLATIN, DEXAMETHASONE, FERROUS FUMARATE, FOLIC ACID, HYDROMORPHONE, LORAZEPAM, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VITAMINS, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,102,478 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Feeling abnormal'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CISPLATIN, CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55, DEXAMETHASONE, FERROUS FUMARATE, FOLIC ACID, HERBALS, HYDROMORPHONE, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,079,933 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle twitching'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CISPLATIN, CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55, DEXAMETHASONE, FERROUS FUMARATE, FOLIC ACID, HERBALS, HYDROMORPHONE, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,079,933 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | CARBOPLATIN, CISPLATIN, LORAZEPAM, PEMETREXED, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,084,822 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervousness'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CISPLATIN, CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55, DEXAMETHASONE, FERROUS FUMARATE, FOLIC ACID, HERBALS, HYDROMORPHONE, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,079,933 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CARBOPLATIN, CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55, DEXAMETHASONE, HERBALS, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,061,486 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Restlessness'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | APREPITANT, CISPLATIN, CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55, DEXAMETHASONE, FERROUS FUMARATE, FOLIC ACID, HERBALS, HYDROMORPHONE, PALONOSETRON, PEMETREXED, TIZANIDINE, URSODIOL, VONOPRAZAN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,079,933 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | CARBOPLATIN, CISPLATIN, LORAZEPAM, PEMETREXED, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,084,822 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | CARBOPLATIN, CISPLATIN, LORAZEPAM, PEMETREXED, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,084,822 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | CARBOPLATIN, CISPLATIN, LORAZEPAM, PEMETREXED, PREGABALIN | DrugsGivenReaction | CC BY-NC | 34720951 | 20,084,822 | 2021 |
What was the administration route of drug 'APREPITANT'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | Oral | DrugAdministrationRoute | CC BY-NC | 34720951 | 20,099,668 | 2021 |
What was the dosage of drug 'CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | 40 MG, OF THE PROBIOTIC | DrugDosageText | CC BY-NC | 34720951 | 20,061,486 | 2021 |
What was the dosage of drug 'FOLIC ACID'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | 0.5 MILLIGRAM | DrugDosageText | CC BY-NC | 34720951 | 20,099,668 | 2021 |
What was the dosage of drug 'PREGABALIN'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | 75 MILLIGRAM, BID | DrugDosageText | CC BY-NC | 34720951 | 20,084,822 | 2021 |
What was the dosage of drug 'VITAMINS'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | 1 GRAM | DrugDosageText | CC BY-NC | 34720951 | 20,099,668 | 2021 |
What was the outcome of reaction 'Feeling abnormal'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | Recovered | ReactionOutcome | CC BY-NC | 34720951 | 20,079,933 | 2021 |
What was the outcome of reaction 'Muscle twitching'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | Recovered | ReactionOutcome | CC BY-NC | 34720951 | 20,079,933 | 2021 |
What was the outcome of reaction 'Nervousness'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | Recovered | ReactionOutcome | CC BY-NC | 34720951 | 20,079,933 | 2021 |
What was the outcome of reaction 'Neuropathy peripheral'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | Recovering | ReactionOutcome | CC BY-NC | 34720951 | 20,102,478 | 2021 |
What was the outcome of reaction 'Restlessness'? | Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious adverse effects of chemotherapy. We experienced carboplatin (CBDCA)-induced akathisia-like CIPN, which was significantly attenuated by pregabalin adminis... | Recovered | ReactionOutcome | CC BY-NC | 34720951 | 20,079,933 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arterial occlusive disease'. | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | ALTEPLASE, ASPIRIN, CLOPIDOGREL BISULFATE, EPTIFIBATIDE, NADROPARIN CALCIUM, TIAPRIDE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34720955 | 20,170,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebellar infarction'. | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | ALTEPLASE, ASPIRIN, CLOPIDOGREL BISULFATE, EPTIFIBATIDE, NADROPARIN CALCIUM, TIAPRIDE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34720955 | 20,170,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vertebral artery occlusion'. | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | ALTEPLASE, ASPIRIN, CLOPIDOGREL BISULFATE, EPTIFIBATIDE, NADROPARIN CALCIUM, TIAPRIDE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34720955 | 20,170,885 | 2021 |
What was the administration route of drug 'ALTEPLASE'? | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34720955 | 20,170,885 | 2021 |
What was the outcome of reaction 'Arterial occlusive disease'? | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | Recovering | ReactionOutcome | CC BY-NC | 34720955 | 20,170,885 | 2021 |
What was the outcome of reaction 'Cerebellar infarction'? | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | Recovering | ReactionOutcome | CC BY-NC | 34720955 | 20,170,885 | 2021 |
What was the outcome of reaction 'Vertebral artery occlusion'? | Repeated Intravenous Thrombolysis in Patients with Recurrent Ischemic Stroke in the Vertebrobasilar Territory.
Acute ischemic vertebrobasilar stroke (AIVBS) is usually associated with poor outcome and prognosis and in case of basilar artery occlusion (BAO) with high mortality. Intravenous thrombolysis (IVT), as a stand... | Recovering | ReactionOutcome | CC BY-NC | 34720955 | 20,170,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | MELPHALAN | DrugsGivenReaction | CC BY-NC | 34720979 | 20,578,027 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated hepatitis'. | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34720979 | 20,491,654 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | MELPHALAN | DrugsGivenReaction | CC BY-NC | 34720979 | 20,578,027 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock haemorrhagic'. | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | HEPARIN SODIUM, IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34720979 | 20,511,426 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small intestinal haemorrhage'. | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | HEPARIN SODIUM, IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34720979 | 20,511,426 | 2021 |
What was the administration route of drug 'MELPHALAN'? | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | Intra-arterial | DrugAdministrationRoute | CC BY-NC | 34720979 | 20,578,027 | 2021 |
What was the dosage of drug 'MELPHALAN'? | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | 6 PERCUTANEOUS HEPATIC PERFUSIONS WITH INTRA-ARTERIAL MELPHALAN | DrugDosageText | CC BY-NC | 34720979 | 20,578,027 | 2021 |
What was the outcome of reaction 'Shock haemorrhagic'? | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | Fatal | ReactionOutcome | CC BY-NC | 34720979 | 20,511,426 | 2021 |
What was the outcome of reaction 'Small intestinal haemorrhage'? | Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma.
Uveal melanoma is the most common primary intraocular tumor in adults and can have varying presentations, although it is frequently asymptomatic. One rare presentation of uveal melanoma is neovascular glaucoma (NVG). We present a case of a 20-year-old ma... | Fatal | ReactionOutcome | CC BY-NC | 34720979 | 20,511,426 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Macular oedema'. | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | FLUOCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC | 34720984 | 19,952,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | FLUOCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC | 34720984 | 19,952,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | FLUOCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC | 34720984 | 19,952,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal laser coagulation'. | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | FLUOCINOLONE ACETONIDE | DrugsGivenReaction | CC BY-NC | 34720984 | 19,952,414 | 2021 |
What was the administration route of drug 'FLUOCINOLONE ACETONIDE'? | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | Intraocular | DrugAdministrationRoute | CC BY-NC | 34720984 | 19,952,414 | 2021 |
What was the outcome of reaction 'Macular oedema'? | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | Recovered | ReactionOutcome | CC BY-NC | 34720984 | 19,952,414 | 2021 |
What was the outcome of reaction 'Rebound effect'? | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | Recovered | ReactionOutcome | CC BY-NC | 34720984 | 19,952,414 | 2021 |
What was the outcome of reaction 'Retinal laser coagulation'? | Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare and progressive disorder that predominantly affects both the eyes of young female individuals and can threaten visual fun... | Recovered | ReactionOutcome | CC BY-NC | 34720984 | 19,952,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | AFATINIB | DrugsGivenReaction | CC BY | 34721009 | 20,045,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | AFATINIB, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34721009 | 20,129,897 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | AFATINIB, CARBOPLATIN, ICOTINIB, PEMETREXED | DrugsGivenReaction | CC BY | 34721009 | 20,061,767 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | AFATINIB | DrugsGivenReaction | CC BY | 34721009 | 20,045,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | AFATINIB | DrugsGivenReaction | CC BY | 34721009 | 20,045,568 | 2021 |
What was the administration route of drug 'AFATINIB'? | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | Oral | DrugAdministrationRoute | CC BY | 34721009 | 20,129,897 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Case Report: Afatinib-Induced Interstitial Pneumonia: Experiences and Lessons From Two Patients.
Background: Afatinib has shown good efficacy in patients harboring uncommon EGFR mutations, but the incidence of afatinib-induced interstitial pneumonia should be alert as its rapid progression. Here, we report two cases of... | Fatal | ReactionOutcome | CC BY | 34721009 | 20,045,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic coagulopathy'. | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | BASILIXIMAB, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, SIROLIMUS, TACROLIMUS, URSODIOL, VINCRISTINE | DrugsGivenReaction | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'BASILIXIMAB'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, INDUCTION THERAPY | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, R-CHOP REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'CYTARABINE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, RCOPDAM REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, R-CHOP REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'ETOPOSIDE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, RCOPDAM REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'HYDROCORTISONE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, RCOPDAM REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'METHOTREXATE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, RCOPDAM REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, PULSE THERAPY | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, MAINTAINENCE THERAPY | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
Pathogenic gain-of-function variants in complement Factor B were identified as causative of atypical Hemolytic Uremic syndrome (aHUS) in 2007. These mutations generate a redu... | UNK, R-CHOP REGIMEN | DrugDosageText | CC BY | 34721423 | 20,173,792 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.